Medical/Pharmaceuticals

MSIG partners with Singapore Cancer Society to raise public awareness on cancer risks

* Through a range of virtual seminars jointly organised with Singapore Cancer Society, MSIG will be educating its stakeholders on the topic of cancer prevention * MSIG will donate $10 for every CancerCare Plus policy sold to support SCS' cancer programmes and patient care services SINGAPORE, ...

2021-04-27 10:00 3208

DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone

SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it has c...

2021-04-27 09:23 2758

Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer

SAN DIEGO, April 26, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based ...

2021-04-26 22:08 3926

CStone Announces NMPA Acceptance of New Drug Application of Selective Inhibitor GAVRETO(R) (Pralsetinib) with Priority Review Designation for the Treatment of Advanced or Metastatic RET-Altered Thyroid Cancer Patients

SUZHOU, China, April 26, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and precision medicines, today announces that the National Medical Products Administration ...

2021-04-26 21:14 4469

One-Stop CLIA Solution with Open Systems and Resources Makes Evolution to Emerging World Healthcare Systems

* Advanced, flexible cooperation models delivered by one-stop CLIA solution can boost government industrialization plans, laboratory technology updates, reagent R&D and localization, and even more investment flows to the industry * COVID-19 NAb Test CLIA Solution coupled with COVID-19 Ag Self ...

2021-04-26 15:17 2534

Mediso completes technology transfer of novel MRI spectrometer

BUDAPEST, Hungary, April 26, 2021 /PRNewswire/ -- Mediso Medical Imaging Systems today announced that it has completed the technology transfer of the new Cameleon4™ MRI spectrometer developed by RS2D (Strasbourg, France). Following the IP transfer, the new console is seamlessly integrated into th...

2021-04-26 09:00 2711

Associates of Cape Cod, Inc. announces launch of PyroSmart NextGen™ Recombinant LAL Reagent

EAST FALMOUTH, Mass., April 23, 2021 /PRNewswire/ -- Associates of Cape Cod, Inc. (ACC), a Seikagaku Group Company, announces the launch of a new, innovative, sustainable recombinant LAL reagent, PyroSmart NextGen™ for Bacterial Endotoxin Testing (BET). The new LAL reagent is sustainably produced...

2021-04-23 22:30 4826

INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800

Given universal eligibility and broad availability of COVID-19 vaccines in the U.S., DoD JPEO-CBRND has notified INOVIO that it will discontinue funding for the Phase 3 INO-4800 trial INOVIO adjusts INO-4800 clinical development strategy to focus on global unmet COVID-19 vaccine needs PLYMOUTH ...

2021-04-23 20:00 5656

OCON's Pioneering IUB™ Ballerine® Femtech Applauded by Frost & Sullivan

OCON's technology has a higher safety profile than traditional IUDs as its built-in safety mechanism allows the device to deploy and position itself away from the uterine walls LONDON, April 23, 2021 /PRNewswire/ -- Based on its recent analysis of the global intrauterine device (IUD) market,Fros...

2021-04-23 17:00 2271

Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova

STOCKHOLM, April 23, 2021 /PRNewswire/ -- Sweden's innovation authority Vinnova is investing in Lipidor's subsidiary Emollivet. The funding from Vinnova is for SEK 300,000 and will be used for a project in which Emollivet, through interaction with animal owners and others in the animal health mark...

2021-04-23 15:22 2170

The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review

SHANGHAI, April 23, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of serplulimab injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb), for the treatment of unresectable or metastatic microsatellite instability-high (MSI-H) s...

2021-04-23 15:00 2593

The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review

SHANGHAI, April 22, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of serplulimab injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb), for the treatment of unresectable or metastatic microsatellite instability-high (MSI-H) s...

2021-04-22 21:47 4164

Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis

STOCKHOLM, April 22, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North: LIPI) today provides an update on the planned Phase III study of the company's drug candidate AKP02 for the treatment of psoriasis. During the first quarter of 2021, Lipidor submitted an application to the Indian Med...

2021-04-22 16:02 2211

RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt

MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF,Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and itsBerlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million ...

2021-04-22 16:00 3625

Tokiwa Phytochemical Co., Ltd. Announces New Cutting-Edge Study Supporting Benefits of SIRTMAX (R) on Healthier Life Expectancy

SAKURA, Japan, April 22, 2021 /PRNewswire/ -- Tokiwa Phytochemical Co., Ltd. (hereinafter "Tokiwa"),Japan, is excited to announce the publication of a joint research project with theUniversity of Tokyo on a proprietary extract of "Kaempferia parviflora" (SIRTMAX (R)), commonly known as black turm...

2021-04-22 14:00 3552

Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year

* Second public procurement agreement after Italy's procurement deal worth EUR 89.3 million SEOUL, South Korea, April 22, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm said it began supplying its COVID-19 diagnostic tests worth16,209,150 GBP to Scotland under a pub...

2021-04-22 09:37 3542

Innovative and Eco-friendly Masks to Provide Silver Lining for Declining Consumer Face Mask Market

For face mask businesses to thrive in the post-COVID-19 era, manufacturers must develop masks with distinct product features, says Frost & Sullivan SANTA CLARA, Calif., April 22, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis on the global consumer face mask market finds that the mature ...

2021-04-22 04:03 2455

endpoint Launches ConnectionPOINT™ - A partnership program designed to power accelerated outcomes and move medicine through next-generation eClinical technology interfacing

SAN FRANCISCO, April 21, 2021 /PRNewswire/ -- endpoint Clinical, the leading global interactive response technology (IRT®) company, announced today the launch of their partnership program,ConnectionPOINT™, the first of its kind in the eClinical technology space.  The program's vision is for a g...

2021-04-21 21:00 3957

Mount Sinai Hospital in New York joins RhoVac's Phase IIb Study in Prostate Cancer

STOCKHOLM, April 21, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,April 21st 2021, that the prestigiousMount Sinai hospital in New York is initiated today as the latest addition to US trial centres in RhoVac's clinical phase IIb study, "BRaVac...

2021-04-21 20:56 2275

Cobots Lead the Future of the Global Industrial Robots Market, Finds Frost & Sullivan

Asia-Pacific to remain the epicenter of growth opportunities for robot manufacturers, with market revenues estimated to top$25.08 billion by 2024 SANTA CLARA, Calif., April 21, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that theglobal industrial robotics market will reach reven...

2021-04-21 20:48 2855
1 ... 379380381382383384385 ... 394

Week's Top Stories